| 2 | Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. (Jaquiss RD, Ghanayem NS, Zacharisen MC, Mussatto KA, Tweddell JS, Litwin SB) Circulation 2002 Sep 24;106(12 Suppl 1):I90-4 46 Citations |
| 1 | Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery. (Arlikar SJ, Atchison CM, Amankwah EK, Ayala IA, Barrett LA, Branchford BR, Streiff MB, Takemoto CM, Goldenberg NA) Thromb Res 2015 Oct;136(4):717-22 64 Citations |
| 1 | Risk factors for hospital-associated venous thromboembolism in critically ill children following cardiothoracic surgery or therapeutic cardiac catheterisation. (Atchison CM, Amankwah E, Wilhelm J, Arlikar S, Branchford BR, Stock A, Streiff M, Takemoto C, Ayala I, Everett A, Stapleton G, Jacobs ML, Jacobs JP, Goldenberg NA) Cardiol Young 2018 Feb;28(2):234-242 31 Citations |
| 1 | Cardiothoracic Surgery in the United Kingdom: Operating Without a Weekend Effect? (Fierro MA, Bartz RR, Bennett-Guerrero E) J Cardiothorac Vasc Anesth 2018 Oct;32(5):2187-2189 |
| 8 | Nuclear Cell-Free DNA Predicts Adverse Events After Pediatric Cardiothoracic Surgery. (Tanem JM, Scott JP, Hoffman GM, Niebler RA, Tomita-Mitchell A, Stamm KD, Liang HL, North PE, Bertrandt RA, Woods RK, Hraska V, Mitchell ME) Ann Thorac Surg 2023 Aug;116(2):349-356 5 Citations |
